“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Velichka Valcheva, CEO.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GHRS:
- GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
- GH Research to Attend APA Annual Meeting in San Francisco in May 2026
- GH Research Raises $111 Million in Completed Share Offering to Fund Depression Pipeline
- Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
- GH Research ‘welcomes’ Executive Order to accelerate mental illness treatments